Wealth Enhancement Advisory Services, LLC Gilead Sciences, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $55.6 Billion
- Q2 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 484,018 shares of GILD stock, worth $55.3 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
484,018
Previous 292,966
65.21%
Holding current value
$55.3 Million
Previous $32.8 Million
63.48%
% of portfolio
0.1%
Previous 0.07%
Shares
21 transactions
Others Institutions Holding GILD
# of Institutions
2,296Shares Held
1BCall Options Held
9.6MPut Options Held
10.1M-
Black Rock Inc. New York, NY121MShares$13.8 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$13.4 Billion0.25% of portfolio
-
State Street Corp Boston, MA59.5MShares$6.8 Billion0.28% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$6.24 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$6.12 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $143B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...